PAREXEL International Corp (NASDAQ:PRXL)

CAPS Rating: 3 out of 5

The Company provides a range of expertise in clinical research, medical communications services, consulting, and informatics and advanced technology products and services to the worldwide pharmaceutical, biotechnology, and medical device industries.

Recs

0
Player Avatar suhsido1 (< 20) Submitted: 9/9/2008 4:58:29 AM : Outperform Start Price: $31.14 PRXL Score: -21.67

Clinical research. 4 star.

Featured Broker Partners


Advertisement